Multi-layer electrode ablation probe and related methods
First Claim
Patent Images
1. A method of delivering an electric field to a target tissue, comprising:
- positioning a first electrode to at least partially define a first treatment volume in the target tissue;
positioning a second electrode to at least partially define a second treatment volume, wherein the first volume is disposed in the second volume;
establishing a first current flow extending radially within the first volume and a second current flow extending through the second volume; and
wherein the first current flow selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within the first treatment volume and the second current flow selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within the second treatment volume.
1 Assignment
0 Petitions
Accused Products
Abstract
Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
98 Citations
16 Claims
-
1. A method of delivering an electric field to a target tissue, comprising:
-
positioning a first electrode to at least partially define a first treatment volume in the target tissue; positioning a second electrode to at least partially define a second treatment volume, wherein the first volume is disposed in the second volume; establishing a first current flow extending radially within the first volume and a second current flow extending through the second volume; and wherein the first current flow selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within the first treatment volume and the second current flow selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within the second treatment volume. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
Specification